The present invention is directed to compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that are aldosterone receptor antagonists which might be useful for treating aldosterone-mediated diseases. The invention furthermore relates to processes for preparing compounds of the Formula (I), to their possible use for the treatment of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula (I).
本发明涉及式(I)的化合物以及其药用盐,这些化合物是
醛固酮受体拮抗剂,可能对治疗
醛固酮介导的疾病有用。该发明还涉及制备式(I)化合物的方法,以及它们可能用于治疗上述疾病和制备用于此目的的药物的方法,以及包括式(I)化合物的药物组合物。